Brokerages Set Amrize Ltd (NYSE:AMRZ) Price Target at $60.50

Shares of Amrize Ltd (NYSE:AMRZGet Free Report) have been given an average recommendation of “Moderate Buy” by the fifteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $60.6667.

Several research analysts recently commented on the stock. Barclays initiated coverage on shares of Amrize in a research note on Tuesday, October 7th. They set an “equal weight” rating for the company. Oppenheimer raised their price objective on Amrize from $62.00 to $64.00 and gave the stock an “outperform” rating in a research report on Thursday. Weiss Ratings raised Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, January 12th. Zacks Research upgraded Amrize from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Finally, Morgan Stanley set a $61.00 price target on Amrize and gave the stock an “overweight” rating in a research note on Wednesday, October 29th.

Check Out Our Latest Research Report on AMRZ

Insider Activity at Amrize

In other news, Director Nicholas C. Gangestad bought 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 19th. The shares were purchased at an average cost of $47.34 per share, with a total value of $94,680.00. Following the transaction, the director directly owned 4,958 shares in the company, valued at approximately $234,711.72. The trade was a 67.61% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jan Philipp Jenisch purchased 55,000 shares of the stock in a transaction on Thursday, October 30th. The shares were purchased at an average cost of $52.64 per share, with a total value of $2,895,200.00. Following the transaction, the chief executive officer owned 1,505,000 shares in the company, valued at $79,223,200. This trade represents a 3.79% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 65,000 shares of company stock worth $3,399,720 in the last quarter.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AMRZ. Vanguard Group Inc. boosted its position in Amrize by 41.0% in the third quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company’s stock valued at $1,468,460,000 after buying an additional 8,743,543 shares during the last quarter. Norges Bank purchased a new stake in shares of Amrize in the 2nd quarter valued at $670,915,000. Dodge & Cox acquired a new stake in shares of Amrize in the second quarter worth $622,085,000. Wellington Management Group LLP increased its stake in shares of Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock worth $561,018,000 after acquiring an additional 3,809,133 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Amrize by 4.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,518,018 shares of the company’s stock worth $459,242,000 after purchasing an additional 420,728 shares during the last quarter.

Amrize Price Performance

Shares of AMRZ stock opened at $54.52 on Thursday. The company’s 50-day moving average is $53.28. Amrize has a 1-year low of $44.12 and a 1-year high of $58.11. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.97 and a current ratio of 1.45. The company has a market capitalization of $30.15 billion and a P/E ratio of 29.63.

Amrize (NYSE:AMRZGet Free Report) last announced its earnings results on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The business had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.49 billion. The firm’s quarterly revenue was up 6.6% compared to the same quarter last year.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

See Also

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.